This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
MIT Technology Review Narrated
00:00
Delivery methods: plasmid vs AAV
Discussion contrasts short-lived plasmids with longer-lasting AAV and their respective safety profiles.
Play episode from 08:27
Transcript
